In industrial countries, stroke remains both the leading cause of acquired disability and the second leading cause of death. On this day ETAP-Lab would like to show its support for stroke patients and their families.
STROK@LLIANCE is proud to support the preclinical development of new therapeutics for health benefits in the field of stroke.
By offering a unique preclinical translational research service that combines the best of academic and private expertise, STROK@LLIANCE is involved in the fight against stroke every single day.
Driven by the need to improve patient care and quality of life, the preclinical models we offer are always inching closer to clinical reality.